pend
avail
vaccin
critic
need
identifi
effect
treatment
number
clinic
trial
implement
worldwid
chloroquin
analog
shown
inhibit
acidif
endosom
exhibit
vitro
non
specif
antivir
activ
high
micromolar
concentr
broad
rang
emerg
viru
hiv
dengu
hepat
c
chikungunya
influenza
ebola
sar
mer
virus
recent
franc
follow
result
clinic
studi
marseil
consider
interest
use
hydroxychloroquin
treat
diseas
french
ministri
health
recent
allow
use
hydroxychloroquin
treat
diseas
pend
result
ongo
clinic
trial
studi
gautret
et
al
report
viral
clearanc
nasopharyng
swab
patient
day
combin
hydroxychloroquin
azithromycin
rate
viral
clearanc
lower
hydroxychloroquin
alon
patient
receiv
hydroxychloroquin
p
rapid
full
viral
clearanc
quit
unexpect
wish
assess
prospect
studi
virolog
clinic
outcom
consecut
patient
hospit
depart
receiv
hydroxychloroquin
mgd
day
azithromycin
mg
day
mg
day
use
dose
regimen
report
gautret
et
al
men
women
mean
age
year
rang
signific
comorbid
associ
poor
outcom
obes
solid
cancer
hematolog
cancer
hivinfect
time
treatment
initi
fever
receiv
nasal
oxygen
therapi
within
day
one
patient
die
two
transfer
icu
one
patient
hydroxychloroquin
azithromycin
discontinu
day
prolong
qt
interv
ms
treatment
ms
combin
mean
blood
concentr
hydroxychloroquin
ngml
rang
day
treatment
initi
repeat
nasopharyng
swab
patient
done
patient
die
use
qualit
pcr
assay
nucleic
acid
extract
use
nuclisen
easi
biomerieux
amplif
realstar
sar
altona
still
posit
rna
patient
confid
interv
day
treatment
initi
virolog
result
stand
contrast
report
gautret
et
al
cast
doubt
strong
antivir
efficaci
combin
furthermor
report
gautret
et
al
also
report
one
death
three
transfer
icu
among
patient
receiv
hydroxychloroquin
also
underlin
poor
clinic
outcom
combin
addit
recent
studi
china
individu
found
differ
rate
virolog
clearanc
day
without
day
hydroxychloroquin
differ
clinic
outcom
durat
hospit
temperatur
normal
radiolog
progress
result
consist
lack
virolog
clinic
benefit
chloroquin
number
viral
infect
assess
treatment
prophylaxi
sometim
deleteri
effect
viral
replic
summari
despit
report
antivir
activ
chloroquin
vitro
found
evid
strong
antivir
activ
clinic
benefit
combin
hydroxychloroquin
azithromycin
treatment
hospit
patient
sever
ongo
random
clinic
trial
hydroxychloroquin
provid
definit
answer
regard
alleg
efficaci
combin
assess
safeti
